Skip to main
PHR

Phreesia Inc (PHR) Stock Forecast & Price Target

Phreesia Inc (PHR) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 20%
Buy 53%
Hold 27%
Sell 0%
Strong Sell 0%

Bulls say

Phreesia is facing intense competition from smaller, scaled, and well-capitalized participants in the healthcare market, but its strong partnerships and diversification efforts through the acquisition of AccessOne are potential growth drivers for the company. However, potential regulatory changes and ongoing litigation surrounding the ConnectOnCall outage pose risks to the company's reputation and business. Despite industry headwinds, Phreesia is expected to maintain its efficient operations and emerge as a higher margin, diversified company.

Bears say

Phreesia is facing several concerning factors that may negatively impact its financial performance. The company has a heavy reliance on its subscription and related services revenue, which has been growing at a slower rate than previously expected. Additionally, the company is facing headwinds in the form of a patent cliff and increasing competition for healthcare advertising budgets. The recent reduction in guidance for its network solutions revenue also raises concerns about the company's ability to maintain growth and profitability. With a relatively high valuation compared to its peers and uncertainties around future growth, a negative outlook is warranted for Phreesia's stock.

Phreesia Inc (PHR) has been analyzed by 15 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 53% recommend Buy, 27% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Phreesia Inc (PHR) Forecast

Analysts have given Phreesia Inc (PHR) a Buy based on their latest research and market trends.

According to 15 analysts, Phreesia Inc (PHR) has a Buy consensus rating as of May 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $19.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $19.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Phreesia Inc (PHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.